BME100 f2017:Group14 W0800 L2: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Shae M. Diaz (talk | contribs) |
Shae M. Diaz (talk | contribs) |
||
| Line 27: | Line 27: | ||
==Fundability== | ==Fundability== | ||
==Resources== | |||
1. NCBI, "The 60-day temperature-dependent degradation of midazolam and Lorazepam in the prehospital environment". | |||
https://www.ncbi.nlm.nih.gov/pubmed/23148574 | |||
Revision as of 19:05, 16 September 2017
TEAM MEMBERS
 |
|
|
|
|
Our Design
Technical Feasibility
Clinical Feasibility
Market Size
Fundability
Resources
1. NCBI, "The 60-day temperature-dependent degradation of midazolam and Lorazepam in the prehospital environment". https://www.ncbi.nlm.nih.gov/pubmed/23148574
